FDA Adverse Event Injury Summary report: N

XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2991566 · Received March 6, 2013

Report

Report Number
2024168-2013-01295
Event Type
Injury
Date Received
March 6, 2013
Date of Event
February 8, 2013
Report Date
February 12, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR EVALUATION. FAILURE TO ADVANCE/CROSS THE LESION COULD NOT BE REPLICATED IN A TESTING ENVIRONMENT AS IT WAS BASED ON OPERATIONAL CIRCUMSTANCES. SHAFT SEPARATION WAS CONFIRMED. BASED ON VISUAL AND DIMENSIONAL ANALYSIS OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. REVIEW OF THE COMPLAINT HISTORY OF THE REPORTED LOT DID NOT INDICATE A MANUFACTURING ISSUE. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT A LESION IN A CALCIFIED PROXIMAL CIRCUMFLEX WITH A 90 DEGREE TURN, A 3.5 X 8 RX XIENCE XPEDITION STENT DELIVERY SYSTEM (SDS) WAS ADVANCED VIA DIRECT STENTING AND RESISTANCE WAS FELT WITH THE PATIENT ANATOMY WHILE TRYING TO MAKE THE 90 DEGREE TURN TO THE TARGET LESION. REPORTEDLY, FORCE WAS APPLIED TO THE SDS AND THE PROXIMAL SHAFT SEPARATED INTO TWO PIECES. THE DISTAL PORTION OF THE SDS WAS SIMPLY WITHDRAWN FROM THE PATIENT ANATOMY. REPORTEDLY, WHILE THE ABBOTT TERRITORY MANAGER WAS WATCHING THE FILMS OF THE PROCEDURE IT LOOKED AS THOUGH A SMALL DISSECTION OCCURRED; HOWEVER, THE PHYSICIAN DID NOT NOTE A DISSECTION IN THE CATH LAB REPORT. A 3.0 X 12 RX XIENCE XPEDITION SDS AND A 3.0 X 8 RX XIENCE XPEDITION SDS WERE BOTH ADVANCED AND IMPLANTED TO SUCCESSFULLY TREAT THE TARGET LESION. THERE WAS NO ADVERSE PATIENT SEQUELAE AND THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
95322 XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 2102241

Patients

Seq Age Sex Outcome Treatment
1 59 YR Other